Nayara.ai vs Onco Access
Nayara.ai vs Onco Access, compared side by side on 11 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nayara.ai is on 54/100 and Onco Access on 15/100.
Where each one leads
Nayara.ai
- our overall score: 54/100 against 15/100
- agent readiness: 44/100 against 26/100
Onco Access
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Nayara.ai | Onco Access |
|---|---|---|
| What it is | AI-driven clinical-grade breast cancer guide for women navigating their journey. | OncoAccess provides a platform for oncology clinical trial matching and patient access. |
| Category | HealthTech, MedTech, AI-Driven Drug Discovery, Clinical Trials | HealthTech, MedTech, Clinical Trials, Drug Discovery |
| Sells toBusiness model | B2C | B2B |
| Offering | Platform | Platform |
| Founded | 2023 | 2023 |
| Headquarters | San Francisco, United States | New York, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Nayara.ai | Onco Access |
|---|---|---|
| Employees | 12 | Not published |
| Total funding | $4.0M | Not published |
| Latest round | Not published | Grant |
| LinkedIn followers | 1,339 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Nayara.ai | Onco Access |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 15/100 |
| Traction | 44/100 | Not published |
| Team | 70/100 | 30/100 |
| Search visibility | 46/100 | 5/100 |
| Quality | 58/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (26/100) |
| Domain ratingLink authority, 0-100 | 10/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Nayara.ai | Onco Access |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Not detected | Cloudflare |
| CMS | Framer | Not detected |
| Analytics | Google Tag Manager | Not detected |
Product and pricing
| Measure | Nayara.ai | Onco Access |
|---|---|---|
| Key features | Emotional Support, Physical Support, Logistics Support, HIPAA-compliant, Clinical-grade guide | Not published |
Nayara.ai vs Onco Access: common questions
Which is better, Nayara.ai or Onco Access?
On our 0-100 score Nayara.ai rates higher (54/100 against 15/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 11 data points above: read the rows that match what you are buying for.
How do Nayara.ai and Onco Access compare on the numbers?
Nayara.ai leads on our overall score (54/100 against 15/100), agent readiness (44/100 against 26/100).
Read the full Nayara.ai review and pricing or the Onco Access review and pricing. You can also browse other Nayara.ai alternatives we track.